Clinical Trial Update: Registry of Etanercept (Enbrel®) In Children With Juvenile Rheumatoid Arthritis

View source ↗

Summary

Clinical trial registry update for etanercept (Enbrel) in children with juvenile idiopathic arthritis shows the study status as completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Juvenile Idiopathic Arthritis

Drugs mentioned

• ENBREL (etanercept)

Snippet

Sponsor: Amgen | Conditions: Juvenile Rheumatoid Arthritis | Status: COMPLETED